Affiliations: Department of Anesthesia and Critical Care, Boston Children's Hospital, Boston, MA, USA | Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Note: [] Corresponding author: Dr. Christine N. Duncan, Dana-Farber Cancer Institute, Department of Pediatric Oncology, 450 Brookline Avenue, Boston, MA, USA. Tel.: +1 617 632 4882; Fax: +1 617 632 1990; E-mail: christine_duncan@dfci.harvard.edu
Abstract: Hematopoietic cell transplantation is a potentially curative therapeutic modality for a wide range of pediatric malignant and nonmalignant diseases. Hematopoietic cell transplantation has evolved over time to include more indications for transplantation and broad-spectrum treatment and supportive care strategies. This review will address the process of transplantation, donor and stem cell sources, complications, and transplantable diseases.